Over the weekend the COVID-19 situation improved all the EU5 countries. Not only did the growth in net active infection rate fall in all countries, but new cases at least stabilized across the region. In particular Italy resumed the fall in the growth of net active cases, reaching 5% on Sunday, and new cases started to fall as well. It…
COVID-19 Europe: J.P. Morgan
A financial market resource for the every-day investor and trader.
-
J.P. Morgan & Merrill Lynch Lay of the Market Land
Seth Golden, , Research Reports, 0
Volatility Review Monetizing the convexity risk premium, US structuredproduct dynamics, Positioning update Implied convexity continues to exhibit very high...
-
Merrill Lynch: Market Outlook
Seth Golden, , Research Reports, 0
Macro Strategy—Trends from around the world show supply chain bottlenecks have been holding back global growth to a degree...
-
Trade Feud Escalates: COME ON!
Seth Golden, , Research Reports, 0
If you had anticipated a wild week via the FOMC rate announcement and press conference, you would have been...
-
-
February Found Little Upside Resistance, But Will March Find Consolidation?
Seth Golden, , Research Reports, 0
Good weekend Finom Group traders/investors! While this is our off-reporting weekend (no proprietary Research Report), we aim to deliver...
-
How Do Cash Holdings Turn Into Equity Holdings?
Seth Golden, , Research Reports, 0
Coming into the trading week, binary risks were looming amidst a rather strong June rally. With the FOMC standing...
-
J.P. Morgan: The other sting in the tail from fiscal policy; higher taxes and the Value rotation
Seth Golden, , Research Reports, 0
Cross-asset strategy: This week’s Fed reiteration that it won’t hike for about three years despite extraordinary fiscal stimulus...
-
Another 10% Correction Morgan Stanley Believes Lay Ahead
Seth Golden, , Research Reports, 0
Weekly Warm-up: ResistanceHolds; Earnings Upside vsMultiple for Stock Selection Last week’s failure to break through technical resistance for second...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00